Dr Kavita Patel, a practicing physician and a policy researcher at the Brookings Institution, writes in her opinion piece that Obamacare has achieved it's purported goals.
The Affordable Care Act had three main priorities: to improve access to health care, control the growing cost of health care spending and improve the quality of services delivered to Americans. Prior to the Affordable Care Act, our system was broken — family premiums for employer coverage doubled over ten years, and in 2009, health spending reached nearly 18 percent of the gross domestic product. Finally, the United States lagged behind other similar countries on infant mortality, obesity and hospital-acquired infections.
As a practicing physician and a policy researcher, I can say that improvements in all three key priority areas are really happening. One of my newest patients is a 52-year-old woman with progressively debilitating shortness of breath. She was working two part-time jobs as a waitress, and could not previously afford health insurance until the Affordable Care Act. I found out she had undiagnosed heart disease, which we were able to diagnose and treat. I am also making sure that she receives other important preventive services, such as breast cancer detection and immunizations. Her quality of life was improved dramatically in a matter of weeks, thanks in large part to the the health care law.
But it’s not just stories from doctors’ offices — we are seeing signs of success across the country.
Read the complete article on the Brookings website: http://brook.gs/12lU1LN
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More